Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Although, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contributing to standardized treatment protocols and improved survival rates.
Epistemonikos ID: 92eb77d91b5ea43e933cdbe200b07ba010aad7b8
First added on: Jan 03, 2026